On the calcium receptor that mediates depolarization-secretion coupling at cholinergic motor nerve terminals

British Journal of Pharmacology
E M Silinsky

Abstract

1 The behaviour of the divalent cations Ca and Sr as agonists for receptors that mediate the synchronous evoked secretion of acetylcholine (ACh) was studied in the hope of determining whether the relationship between Ca binding and ACh secretion is determined only by the law of mass action or by the mathematical framework of receptor theory. Experiments were designed to evaluate the assumption that maximum effect requires occupation of all receptors by testing for the presence of spare Ca receptors on presynaptic terminals. Frog cutaneous nerve-muscle preparations were employed in conjunction with conventional electrophysiological methods.2 Curves of log [Ca] or log [Sr] against the mean number of ACh quanta released (m) were constructed to saturation. The log [Sr]-m relationship was shifted to the right and had a smaller maximum than the log [Ca]-m curve. This suggests that Ca has a higher efficacy than Sr and raises the possibility that spare binding sites are present for Ca.3 As a qualitative test for spare Ca receptors, La(3+) (>/=0.5 mum) or 2-chloroadenosine (25 mum) was employed as an irreversible antagonist of the effects of extracellular Ca on evoked ACh release. Despite the irreversible blockade of a proportion of rec...Continue Reading

References

Dec 4, 1978·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·B Katz, R Miledi
May 1, 1979·Biophysical Journal·D A Nachshen, M P Blaustein
Jun 1, 1976·Journal of Theoretical Biology·A R Martin
Oct 1, 1975·The Journal of Physiology·E M Landau, D A Nachshen
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·C Londos, J Wolff
Aug 1, 1979·The Journal of Physiology·D ColquhounR E Sheridan
Apr 28, 1978·Annals of the New York Academy of Sciences·A M BrownK S Lee
Aug 1, 1976·Biophysical Journal·C F Stevens
Mar 1, 1971·The Journal of Physiology·A Auerbach, W Betz
Aug 1, 1972·The Journal of Physiology·B L Ginsborg, G D Hirst
Nov 1, 1973·The Journal of Physiology·J N Weakly
Jan 1, 1971·Journal of Neurobiology·W A DeBassioR L Parsons
Dec 14, 1971·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J Heuser, R Miledi
Apr 22, 1974·Pflügers Archiv : European journal of physiology·F Dreyer, K Peper
Jan 1, 1973·Progress in Biophysics and Molecular Biology·H Reuter
May 1, 1974·The Journal of General Physiology·S HagiwaraD C Eaton
May 14, 1971·Nature·H P Rang
Apr 21, 1972·Science·U Meiri, R Rahamimoff
Apr 1, 1967·The Journal of Physiology·B Katz, R Miledi
Nov 1, 1967·The Journal of Physiology·F A Dodge, R Rahamimoff
Jan 1, 1980·British Journal of Pharmacology·E M Silinsky
May 1, 1981·The Journal of Physiology·E D KharaschE M Silinsky
Jun 28, 1954·The Journal of Physiology·J DEL CASTILLO, B KATZ
Oct 28, 1955·The Journal of Physiology·A R MARTIN
Dec 1, 1956·British Journal of Pharmacology and Chemotherapy·R P STEPHENSON
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Nov 28, 1951·The Journal of Physiology·P FATT, B KATZ
Mar 18, 1926·The Journal of Physiology·J H Gaddum
Sep 1, 1947·British Journal of Pharmacology and Chemotherapy·H O SCHILD

❮ Previous
Next ❯

Citations

Sep 1, 1982·Cellular and Molecular Neurobiology·R P Ebstein, J W Daly
Jan 1, 1986·Progress in Neurobiology·J A Ribeiro, A M Sebastião
Jan 1, 1990·Experimental Gerontology·F Laghi PasiniT Di Perri
Oct 1, 1994·British Journal of Pharmacology·R S Redman, E M Silinsky
Apr 4, 2008·Journal of Neurophysiology·Timothy J Searl, Eugene M Silinsky
Jan 1, 1990·Annals of the New York Academy of Sciences·E M SilinskyJ K Hirsh
Mar 1, 1984·British Journal of Pharmacology·G BurnstockC H Hoyle
Apr 1, 1985·British Journal of Pharmacology·J A Ribeiro, A M Sebastião
Jan 1, 1989·Annals of the New York Academy of Sciences·D W WrayC Peers
Jan 1, 1990·Immunopharmacology and Immunotoxicology·F L PasiniE Gaggelli
May 16, 2001·Journal of Neurophysiology·M Moyer, E van Lunteren

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.